Nausherwan Burki is a Respiratory physician affiliated with UConn Health. OpenAlex indexes 28 publications with 855 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
263 Farmington Ave
Farmington, CT 060300001
Telephone
860-679-3343Registry record last updated 29 Sept 2022.
Clinical trials
- Enhancement of Corticosteroid Efficacy in COPD
Sponsor: UConn Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202518 payments
- Masimo CorporationProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%beta2-Adrenergic Agonist69.4%Ventolin Hfa54%Albuterol Sulfate Hfa47%Part D<11 patientsCorticosteroid30.6%Symbicort100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2004–2007 per NIH RePORTER. The latest:
- PULMONARY EPITHELIAL EFFECTS OF HYPOXIA
University of Connecticut Sch of Med/dnt
FY2007$1,725M01RR006192 - CO2 PRODUCTION AND VENTILATION IN COPD
University of Connecticut Sch of Med/dnt
FY2006$8,383M01RR006192
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lipoid Pneumonia and Sarcoidosis.
PubMed
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Martha Radford, MD
UConn Health
David Steffens, MD
UConn Health
Peter Albertsen, MD
UConn Health
Mark Metersky, MD
UConn Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”